There is also evidence that PCSCs might come from the basal cell layer, because tissue-derived tumor-initiating cells in immunocompromised mice expressed basal markers (such as p63), but did not express the androgen receptor (AR) or markers of luminal differentiation (PSA and PAP) (64). The gene discussed is AR; the disease is neoplasm.